Federal funding ensures that hemophilia treatment centers can properly care for those with bleeding disorders, columnist Jennifer Lynne says.

Hemophilia A patients with self-described problem joints were found to have worse clinical outcomes, with more pain, in a new study.

With hemophilia, it's easy to assume that joint pain is caused by bleeding. But that's not always the case, columnist G ...

Hemlibra was found to ease pain and improve quality of life for hemophilia A patients, even those with long-term joint damage ...

For columnist Joe MacDonald, the many additional costs associated with his son's hospitalizations made managing finances a challenge.

Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...

MacDonald wonders what format a reality TV show might take to best capture the lives of people with hemophilia.

Commuting in metro areas, whether by public or private transportation, is tricky for people with hemophilia, says columnist.

Metagenomi is now working on preclinical studies to advance MGX-001, its experimental gene-editing therapy for hemophilia A, with the goal of bringing the treatment candidate into clinical trials in ...

After having a bad experience getting three vaccines at once, columnist Jennifer Lynne says that next time, she'll space them apart.

Emergency preparedness is a broad and crucial topic, especially for those of us in the bleeding disorders community. With natural disasters becoming more frequent and severe across the U.S. — think of ...

For the first time in Denmark, people with hemophilia B have been treated with the gene therapy Hemgenix (etranacogene dezaparvovec), according to an announcement from CSL Behring, the company that ...